As of January 22, 2025, Jubilant Pharmova (JUBLPHARMA.NS) has a market cap of $1.72 billion USD. According to our data, Jubilant Pharmova is ranked No.4382 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.72 B |
-15.12%
|
Dec 31, 2024 | $2.03 B |
103.80%
|
Dec 29, 2023 | $0.99 B |
47.37%
|
Dec 30, 2022 | $0.67 B |
-35.19%
|
Dec 31, 2021 | $1.04 B |
-6.78%
|
Dec 31, 2020 | $1.12 B |
59.55%
|
Dec 31, 2019 | $0.70 B |
-23.52%
|
Dec 31, 2018 | $0.91 B |
-9.39%
|
Dec 29, 2017 | $1.01 B |
25.43%
|
Dec 30, 2016 | $0.80 B |
55.10%
|
Dec 31, 2015 | $0.52 B |
243.00%
|
Dec 31, 2014 | $0.15 B |
-8.59%
|
Dec 31, 2013 | $0.17 B |
-36.86%
|
Dec 31, 2012 | $0.26 B |
28.02%
|
Dec 30, 2011 | $0.20 B |
-34.51%
|
Dec 31, 2010 | $0.31 B |
-11.71%
|
Dec 31, 2009 | $0.35 B |
184.62%
|
Dec 31, 2008 | $0.12 B |
-65.28%
|
Dec 31, 2007 | $0.36 B |
43.89%
|
Dec 29, 2006 | $0.25 B |
465.19%
|
Dec 30, 2005 | $44.05 M |
36.13%
|
Dec 31, 2004 | $32.35 M |
59.38%
|
Dec 31, 2003 | $20.30 M |
686.76%
|
Dec 31, 2002 | $2.58 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Novo Nordisk A/S
NOVO-B.CO
|
$364.73 B |
95.429 B
|
Denmark
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Roche
ROG.SW
|
$243.80 B |
38.055 B
|
Switzerland
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
CSL
CSL.AX
|
$82.04 B |
-0.000 M
|
Australia
|
Zoetis
ZTS
|
$75.18 B |
-0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Chugai Pharmaceutical
4519.T
|
$69.56 B |
0.452 B
|
Japan
|
Market Cap | = | JUBLPHARMA.NS Stock Price | * | JUBLPHARMA.NS Shares Outstanding |
= | $10.85 | * | 0.16 B | |
= | $1.72 B |